Speaker illustration

Doctor Ina Bregvadze

The center of vascular and heart diseases, Tbilisi (Georgia)

Member of:

European Heart Rythm Association

The predictors of the efficacy of pharmacological cardioversion with class III antiarrhythmic drug - nibentan in patients with persistent atrial fibrillation

Event: ESC CONGRESS 2017

Topic: Electrocardiography

Session: Electrocardiography + cardioversion

Thumbnail

This platform is supported by

logo Novo Nordisk